Cancer Genomics and Metabolomics

Cancer genomics is the study of the totality of DNA sequence and gene expression differences between tumour cells and normal host cells. It aims to understand the genetic basis of tumour cell proliferation and the evolution of the cancer genome under mutation and selection by the body environment, the immune system and therapeutic interventions. Metabolomics research is being used to discover diagnostic cancer biomarkers in the clinic, to better understand its complex heterogeneous nature, to discover pathways involved in cancer that could be used for new targets and to monitor metabolic biomarkers during therapeutic intervention. These metabolomics approaches may also provide clues to personalized cancer treatments by providing useful information to the clinician about the cancer patient’s response to medical interventions. The ultimate goal of most metabolomics cancer studies is to discover cancer-specific diagnostic, prognostic or predictive biomarkers for a patient.

    Related Conference of Cancer Genomics and Metabolomics

    November 06-07, 2017

    2nd International Conference on Autoimmunity

    Frankfurt, Germany
    November 08-09, 2017

    3rd Antibodies and Bio Therapeutics Congress & B2B

    Las Vegas, Nevada, USA
    November 13-14, 2017

    5th International Conference on HIV/AIDS, STDs and STIs

    Las Vegas, Nevada, USA
    Dec 14-15, 2017

    World Immunology Congress

    Dubai, UAE
    May 28-29, 2018

    World Congress on Allergy and Immunotherapy

    Osaka, Japan

    9th European Immunology Conference

    June 14-16, 2018 Rome, Italy
    July 12-13, 2018

    5th International Conference on Parasitology

    Paris, France

    Cancer Genomics and Metabolomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in